A Danish biotechnology company focused on developing antibody-based therapies for cancer and other serious diseases. Its business model centers on proprietary antibody platforms and partnerships with large pharmaceutical companies, generating significant royalty revenue from marketed drugs such as m...
1 member of Congress has disclosed 1 trade in genmab a/S american Depositary (GMXAY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-05-28 | Mikie Sherrill | sell | $1K – $15K |